BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Caminati A, Bianchi A, Cassandro R, Rosa Mirenda M, Harari S. Walking distance on 6-MWT is a prognostic factor in idiopathic pulmonary fibrosis. Respiratory Medicine 2009;103:117-23. [DOI: 10.1016/j.rmed.2008.07.022] [Cited by in Crossref: 71] [Cited by in F6Publishing: 62] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Massierer D, Bourgeois N, Räkel A, Prévost K, Lands LC, Poirier C, Janaudis-Ferreira T. Changes in 6-minute walking distance in lung transplant candidates while participating in a home-based pre-habilitation program-A retrospective chart review. Clin Transplant 2020;34:e14045. [PMID: 32686160 DOI: 10.1111/ctr.14045] [Reference Citation Analysis]
2 Raghu G, Martinez FJ, Brown KK, Costabel U, Cottin V, Wells AU, Lancaster L, Gibson KF, Haddad T, Agarwal P, Mack M, Dasgupta B, Nnane IP, Flavin SK, Barnathan ES. CC-chemokine ligand 2 inhibition in idiopathic pulmonary fibrosis: a phase 2 trial of carlumab. Eur Respir J 2015;46:1740-50. [PMID: 26493793 DOI: 10.1183/13993003.01558-2014] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 7.9] [Reference Citation Analysis]
3 Ley B, Collard HR, King TE. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011;183:431-440. [PMID: 20935110 DOI: 10.1164/rccm.201006-0894CI] [Cited by in Crossref: 847] [Cited by in F6Publishing: 431] [Article Influence: 70.6] [Reference Citation Analysis]
4 Vainshelboim B. Exercise training in idiopathic pulmonary fibrosis: is it of benefit? Breathe (Sheff) 2016;12:130-8. [PMID: 27408631 DOI: 10.1183/20734735.006916] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
5 Solomon JJ, Chung JH, Cosgrove GP, Demoruelle MK, Fernandez-perez ER, Fischer A, Frankel SK, Hobbs SB, Huie TJ, Ketzer J, Mannina A, Olson AL, Russell G, Tsuchiya Y, Yunt ZX, Zelarney PT, Brown KK, Swigris JJ. Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J 2016;47:588-96. [DOI: 10.1183/13993003.00357-2015] [Cited by in Crossref: 142] [Cited by in F6Publishing: 120] [Article Influence: 20.3] [Reference Citation Analysis]
6 Wallaert B, Monge E, Le Rouzic O, Wémeau-Stervinou L, Salleron J, Grosbois JM. Physical activity in daily life of patients with fibrotic idiopathic interstitial pneumonia. Chest 2013;144:1652-8. [PMID: 23928896 DOI: 10.1378/chest.13-0806] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 5.8] [Reference Citation Analysis]
7 du Bois RM, Weycker D, Albera C, Bradford WZ, Costabel U, Kartashov A, Lancaster L, Noble PW, Raghu G, Sahn SA. Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011;184:459-466. [PMID: 21616999 DOI: 10.1164/rccm.201011-1790oc] [Cited by in Crossref: 254] [Cited by in F6Publishing: 100] [Article Influence: 23.1] [Reference Citation Analysis]
8 Serajeddini H, Rogliani P, Mura M. Multi-dimensional Assessment of IPF Across a Wide Range of Disease Severity. Lung 2018;196:707-13. [DOI: 10.1007/s00408-018-0152-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
9 Meyer KC, Danoff SK, Lancaster LH, Nathan SD. Management of Idiopathic Pulmonary Fibrosis in the Elderly Patient: Addressing Key Questions. Chest 2015;148:242-52. [PMID: 26149553 DOI: 10.1378/chest.14-2475] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
10 Baddini-Martinez JA. Six-minute walk test in patients with idiopathic pulmonary fibrosis. J Bras Pneumol 2018;44:257-8. [PMID: 30328922 DOI: 10.1590/S1806-37562018000040001] [Reference Citation Analysis]
11 Jo HE, Glaspole I, Moodley Y, Chapman S, Ellis S, Goh N, Hopkins P, Keir G, Mahar A, Cooper W, Reynolds P, Haydn Walters E, Zappala C, Grainge C, Allan H, Macansh S, Corte TJ. Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry. BMC Pulm Med 2018;18:19. [PMID: 29370786 DOI: 10.1186/s12890-018-0575-y] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 9.5] [Reference Citation Analysis]
12 Yasui K, Yuda S, Abe K, Asanuma K, Yanagihara N, Sudo Y, Ikeda K, Muranaka A, Otsuka M, Nagahara D, Ohnishi H, Takahashi H, Miura T, Takahashi S. Prognostic value of 6-min walk stress echocardiography in patients with interstitial lung disease. J Echocardiogr 2021. [PMID: 34091856 DOI: 10.1007/s12574-021-00532-x] [Reference Citation Analysis]
13 Nathan SD, du Bois RM, Albera C, Bradford WZ, Costabel U, Kartashov A, Noble PW, Sahn SA, Valeyre D, Weycker D. Validation of test performance characteristics and minimal clinically important difference of the 6-minute walk test in patients with idiopathic pulmonary fibrosis. Respir Med. 2015;109:914-922. [PMID: 25956020 DOI: 10.1016/j.rmed.2015.04.008] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 5.9] [Reference Citation Analysis]
14 King CS, Aryal S, Nathan SD. Idiopathic Pulmonary Fibrosis: Phenotypes and Comorbidities. In: Meyer KC, Nathan SD, editors. Idiopathic Pulmonary Fibrosis. Cham: Springer International Publishing; 2019. pp. 273-97. [DOI: 10.1007/978-3-319-99975-3_11] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Vainshelboim B, Fox BD, Oliveira J, Kramer MR. Exercise training in idiopathic pulmonary fibrosis. Expert Rev Respir Med 2016;10:69-77. [PMID: 26567878 DOI: 10.1586/17476348.2016.1121104] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
16 Spagnolo P, Cocconcelli E, Cottin V. Clinical Trials in IPF: What Are the Best Endpoints? In: Meyer KC, Nathan SD, editors. Idiopathic Pulmonary Fibrosis. Cham: Springer International Publishing; 2019. pp. 433-53. [DOI: 10.1007/978-3-319-99975-3_19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Luppi F, Sebastiani M, Sverzellati N, Cavazza A, Salvarani C, Manfredi A. Lung complications of Sjogren syndrome. Eur Respir Rev 2020;29:200021. [PMID: 32817113 DOI: 10.1183/16000617.0021-2020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
18 Mori S. Management of Rheumatoid Arthritis Patients with Interstitial Lung Disease: Safety of Biological Antirheumatic Drugs and Assessment of Pulmonary Fibrosis. Clin Med Insights Circ Respir Pulm Med 2015;9:41-9. [PMID: 26401101 DOI: 10.4137/CCRPM.S23288] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
19 Sharp C, Adamali HI, Millar AB. A comparison of published multidimensional indices to predict outcome in idiopathic pulmonary fibrosis. ERJ Open Res 2017;3:00096-2016. [PMID: 28326312 DOI: 10.1183/23120541.00096-2016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
20 Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788-824. [PMID: 21471066 DOI: 10.1164/rccm.2009-040gl] [Cited by in Crossref: 4088] [Cited by in F6Publishing: 1877] [Article Influence: 371.6] [Reference Citation Analysis]
21 Caminati A, Harari S. IPF: New insight in diagnosis and prognosis. Respiratory Medicine 2010;104:S2-S10. [DOI: 10.1016/j.rmed.2010.03.012] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
22 Vainshelboim B, Kramer MR, Izhakian S, Lima RM, Oliveira J. Physical Activity and Exertional Desaturation Are Associated with Mortality in Idiopathic Pulmonary Fibrosis. J Clin Med 2016;5:E73. [PMID: 27548238 DOI: 10.3390/jcm5080073] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
23 Rochester CL, Fairburn C, Crouch RH. Pulmonary rehabilitation for respiratory disorders other than chronic obstructive pulmonary disease. Clin Chest Med. 2014;35:369-389. [PMID: 24874132 DOI: 10.1016/j.ccm.2014.02.016] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 5.0] [Reference Citation Analysis]
24 Akihiko S, Tomohiro H, Toru O, Kiminobu T, Kohei I, Yoshinari N, Takeshi K, Kumiko K, Kazuo C, Michiaki M. The association between health-related quality of life and disease progression in idiopathic pulmonary fibrosis: a prospective cohort study. Sarcoidosis Vasc Diffuse Lung Dis 2017;34:226-35. [PMID: 32476850 DOI: 10.36141/svdld.v34i3.5214] [Reference Citation Analysis]
25 Barman A, Sinha MK, Sahoo J, Jena D, Patel V. Respiratory Rehabilitation in Patients Recovering from Severe Acute Respiratory Syndrome: A Systematic Review and Meta-analysis. Heart & Lung 2022. [DOI: 10.1016/j.hrtlng.2022.01.005] [Reference Citation Analysis]
26 Furukawa T, Taniguchi H, Ando M, Kondoh Y, Kataoka K, Nishiyama O, Johkoh T, Fukuoka J, Sakamoto K, Hasegawa Y. The St. George's Respiratory Questionnaire as a prognostic factor in IPF. Respir Res 2017;18:18. [PMID: 28095852 DOI: 10.1186/s12931-017-0503-3] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 7.6] [Reference Citation Analysis]
27 Nathan SD, Meyer KC. IPF clinical trial design and endpoints. Curr Opin Pulm Med 2014;20:463-71. [PMID: 25022315 DOI: 10.1097/MCP.0000000000000091] [Cited by in Crossref: 41] [Cited by in F6Publishing: 12] [Article Influence: 5.9] [Reference Citation Analysis]
28 Kenn K, Gloeckl R, Heinzelmann I, Kneidinger N. Nonpharmacological interventions: rehabilitation, palliative care and transplantation. In: Costabel U, Crestani B, Wells AU, editors. Idiopathic Pulmonary Fibrosis. European Respiratory Society; 2016. pp. 230-42. [DOI: 10.1183/2312508x.10006315] [Cited by in Crossref: 3] [Reference Citation Analysis]
29 Dajczman E, Wardini R, Kasymjanova G, Préfontaine D, Baltzan MA, Wolkove N. Six minute walk distance is a predictor of survival in patients with chronic obstructive pulmonary disease undergoing pulmonary rehabilitation. Can Respir J 2015;22:225-9. [PMID: 26252533 DOI: 10.1155/2015/280187] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
30 Chéhère B, Bougault V, Chenivesse C, Grosbois JM, Wallaert B. Cardiorespiratory adaptation during 6-Minute Walk Test in fibrotic idiopathic interstitial pneumonia patients who did or did not respond to pulmonary rehabilitation. Eur J Phys Rehabil Med 2019;55:103-12. [PMID: 29904044 DOI: 10.23736/S1973-9087.18.05093-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Koons B, Greenland JR, Diamond JM, Singer JP. Pathobiology of frailty in lung disease. Transl Res 2020;221:1-22. [PMID: 32376405 DOI: 10.1016/j.trsl.2020.04.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
32 Chéhère B, Bougault V, Gicquello A, Wallaert B. Cardiorespiratory Response to Different Exercise Tests in Interstitial Lung Disease. Med Sci Sports Exerc 2016;48:2345-52. [PMID: 27434081 DOI: 10.1249/MSS.0000000000001051] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
33 Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, Hill K, Holland AE, Lareau SC, Man WD, Pitta F, Sewell L, Raskin J, Bourbeau J, Crouch R, Franssen FM, Casaburi R, Vercoulen JH, Vogiatzis I, Gosselink R, Clini EM, Effing TW, Maltais F, van der Palen J, Troosters T, Janssen DJ, Collins E, Garcia-Aymerich J, Brooks D, Fahy BF, Puhan MA, Hoogendoorn M, Garrod R, Schols AM, Carlin B, Benzo R, Meek P, Morgan M, Rutten-van Mölken MP, Ries AL, Make B, Goldstein RS, Dowson CA, Brozek JL, Donner CF, Wouters EF; ATS/ERS Task Force on Pulmonary Rehabilitation. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013;188:e13-64. [PMID: 24127811 DOI: 10.1164/rccm.201309-1634ST] [Cited by in Crossref: 1479] [Cited by in F6Publishing: 639] [Article Influence: 164.3] [Reference Citation Analysis]
34 Swimmer RA, Rozanski EA. Evaluation of the 6-minute walk test in pet dogs. J Vet Intern Med 2011;25:405-6. [PMID: 21352372 DOI: 10.1111/j.1939-1676.2011.0689.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
35 Suzuki M, Kawata N, Abe M, Yokota H, Anazawa R, Matsuura Y, Ikari J, Matsuoka S, Tsushima K, Tatsumi K. Objective quantitative multidetector computed tomography assessments in patients with combined pulmonary fibrosis with emphysema: Relationship with pulmonary function and clinical events. PLoS One 2020;15:e0239066. [PMID: 32941486 DOI: 10.1371/journal.pone.0239066] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 DePew ZS, Karpman C, Novotny PJ, Benzo RP. Correlations between gait speed, 6-minute walk distance, physical activity, and self-efficacy in patients with severe chronic lung disease. Respir Care 2013;58:2113-9. [PMID: 23696689 DOI: 10.4187/respcare.02471] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 5.0] [Reference Citation Analysis]
37 Soares Pires F, Caetano Mota P, Melo N, Costa D, Jesus J, Cunha R, Guimarães S, Souto-moura C, Morais A. Fibrose pulmonar idiopática: apresentação clínica, evolução e fatores de prognóstico basais numa coorte portuguesa. Revista Portuguesa de Pneumologia 2013;19:19-27. [DOI: 10.1016/j.rppneu.2012.05.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
38 Harari S, Caminati A. IPF: new insight on pathogenesis and treatment. Allergy 2010;65:537-53. [DOI: 10.1111/j.1398-9995.2009.02305.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 59] [Article Influence: 5.3] [Reference Citation Analysis]
39 Yoon HY, Lee SH, Ha S, Ryu JS, Song JW. The Value of 18F-FDG PET/CT in Evaluating Disease Severity and Prognosis in Idiopathic Pulmonary Fibrosis Patients. J Korean Med Sci 2021;36:e257. [PMID: 34697928 DOI: 10.3346/jkms.2021.36.e257] [Reference Citation Analysis]
40 Thomeer M, Grutters JC, Wuyts WA, Willems S, Demedts MG. Clinical use of biomarkers of survival in pulmonary fibrosis. Respir Res 2010;11:89. [PMID: 20584284 DOI: 10.1186/1465-9921-11-89] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
41 Lancaster L, Fieuw A, Meulemans J, Ford P, Nathan SD. Standardization of the 6-min walk test in clinical trials of idiopathic pulmonary fibrosis. Contemp Clin Trials 2021;100:106227. [PMID: 33246099 DOI: 10.1016/j.cct.2020.106227] [Reference Citation Analysis]
42 Rozenberg D, Singer LG, Herridge M, Goldstein R, Wickerson L, Chowdhury NA, Mathur S. Evaluation of Skeletal Muscle Function in Lung Transplant Candidates. Transplantation 2017;101:2183-91. [PMID: 28376036 DOI: 10.1097/TP.0000000000001754] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 3.4] [Reference Citation Analysis]
43 Whelan TP. Lung transplantation for interstitial lung disease. Clin Chest Med 2012;33:179-89. [PMID: 22365254 DOI: 10.1016/j.ccm.2011.12.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
44 Holland AE. Exercise limitation in interstitial lung disease - mechanisms, significance and therapeutic options. Chron Respir Dis 2010;7:101-11. [PMID: 20056733 DOI: 10.1177/1479972309354689] [Cited by in Crossref: 73] [Cited by in F6Publishing: 62] [Article Influence: 6.1] [Reference Citation Analysis]
45 King CS, Nathan SD. Idiopathic pulmonary fibrosis: effects and optimal management of comorbidities. The Lancet Respiratory Medicine 2017;5:72-84. [DOI: 10.1016/s2213-2600(16)30222-3] [Cited by in Crossref: 81] [Cited by in F6Publishing: 39] [Article Influence: 16.2] [Reference Citation Analysis]
46 Lilja-Maula LI, Laurila HP, Syrjä P, Lappalainen AK, Krafft E, Clercx C, Rajamäki MM. Long-term outcome and use of 6-minute walk test in West Highland White Terriers with idiopathic pulmonary fibrosis. J Vet Intern Med 2014;28:379-85. [PMID: 24417616 DOI: 10.1111/jvim.12281] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
47 Mancuzo EV, Soares MR, Pereira CAC. Six-minute walk distance and survival time in patients with idiopathic pulmonary fibrosis in Brazil. J Bras Pneumol 2018;44:267-72. [PMID: 30328926 DOI: 10.1590/S1806-37562018000000049] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
48 Gomes-neto M, Silva CM, Ezequiel D, Conceição CS, Saquetto M, Machado AS. Impact of Pulmonary Rehabilitation on Exercise Tolerance and Quality of Life in Patients With Idiopathic Pulmonary Fibrosis: A SYSTEMATIC REVIEW AND META-ANALYSIS. Journal of Cardiopulmonary Rehabilitation and Prevention 2018;38:273-8. [DOI: 10.1097/hcr.0000000000000273] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 5.3] [Reference Citation Analysis]
49 Wuyts WA, Dahlqvist C, Slabbynck H, Schlesser M, Gusbin N, Compere C, Maddens S, Lee YC, Kirchgaessler KU, Bartley K, Bondue B. Longitudinal clinical outcomes in a real-world population of patients with idiopathic pulmonary fibrosis: the PROOF registry. Respir Res 2019;20:231. [PMID: 31651324 DOI: 10.1186/s12931-019-1182-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
50 Vainshelboim B, Kramer MR, Myers J, Unterman A, Izhakian S, Oliveira J. 8-Foot-Up-and-Go Test is Associated with Hospitalizations and Mortality in Idiopathic Pulmonary Fibrosis: A Prospective Pilot Study. Lung 2019;197:81-8. [PMID: 30600393 DOI: 10.1007/s00408-018-0189-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
51 Kundu S, Mitra S, Ganguly J, Mukherjee S, Ray S, Mitra R. Spectrum of diffuse parenchymal lung diseases with special reference to idiopathic pulmonary fibrosis and connective tissue disease: An eastern India experience. Lung India 2014;31:354-60. [PMID: 25378843 DOI: 10.4103/0970-2113.142115] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
52 du Bois RM, Weycker D, Albera C, Bradford WZ, Costabel U, Kartashov A, Lancaster L, Noble PW, Sahn SA, Szwarcberg J. Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference. Am J Respir Crit Care Med. 2011;183:1231-1237. [PMID: 21131468 DOI: 10.1164/rccm.201007-1179oc] [Cited by in Crossref: 247] [Cited by in F6Publishing: 92] [Article Influence: 20.6] [Reference Citation Analysis]
53 Brown AW, Nathan SD. The Value and Application of the 6-Minute-Walk Test in Idiopathic Pulmonary Fibrosis. Annals ATS 2018;15:3-10. [DOI: 10.1513/annalsats.201703-244fr] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 5.8] [Reference Citation Analysis]
54 Harada J, Nagata K, Morimoto T, Iwata K, Matsunashi A, Sato Y, Tachikawa R, Ishikawa A, Tomii K. Effect of high-flow nasal cannula oxygen therapy on exercise tolerance in patients with idiopathic pulmonary fibrosis: A randomized crossover trial. Respirology 2021. [PMID: 34729862 DOI: 10.1111/resp.14176] [Reference Citation Analysis]
55 Bloem AEM, Veltkamp M, Spruit MA, Custers JWH, Bakker EWP, Dolk HM, Grutters JC. Validation of 4-meter-gait-speed test and 5-repetitions-sit-to-stand test in patients with pulmonary fibrosis: a clinimetric validation study. Sarcoidosis Vasc Diffuse Lung Dis 2018;35:317-26. [PMID: 32476919 DOI: 10.36141/svdld.v35i4.7035] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
56 Pimenta SP, Rocha RB, Baldi BG, Kawassaki Ade M, Kairalla RA, Carvalho CR. Desaturation - distance ratio: a new concept for a functional assessment of interstitial lung diseases. Clinics (Sao Paulo) 2010;65:841-6. [PMID: 21049210 DOI: 10.1590/s1807-59322010000900005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
57 Singh SJ, Puhan MA, Andrianopoulos V, Hernandes NA, Mitchell KE, Hill CJ, Lee AL, Camillo CA, Troosters T, Spruit MA, Carlin BW, Wanger J, Pepin V, Saey D, Pitta F, Kaminsky DA, Mccormack MC, Macintyre N, Culver BH, Sciurba FC, Revill SM, Delafosse V, Holland AE. An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease. Eur Respir J 2014;44:1447-78. [DOI: 10.1183/09031936.00150414] [Cited by in Crossref: 343] [Cited by in F6Publishing: 313] [Article Influence: 42.9] [Reference Citation Analysis]
58 Berend N. Respiratory disease and respiratory physiology: putting lung function into perspective interstitial lung disease. Respirology 2014;19:952-9. [PMID: 25039623 DOI: 10.1111/resp.12348] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
59 Watanabe F, Taniguchi H, Sakamoto K, Kondoh Y, Kimura T, Kataoka K, Ogawa T, Arizono S, Nishiyama O, Hasegawa Y. Quadriceps weakness contributes to exercise capacity in nonspecific interstitial pneumonia. Respiratory Medicine 2013;107:622-8. [DOI: 10.1016/j.rmed.2012.12.013] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
60 Holland AE, Dowman L, Fiore J Jr, Brazzale D, Hill CJ, McDonald CF. Cardiorespiratory responses to 6-minute walk test in interstitial lung disease: not always a submaximal test. BMC Pulm Med 2014;14:136. [PMID: 25113781 DOI: 10.1186/1471-2466-14-136] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
61 Lancaster LH. Utility of the six-minute walk test in patients with idiopathic pulmonary fibrosis. Multidiscip Respir Med 2018;13:45. [PMID: 30559965 DOI: 10.1186/s40248-018-0158-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
62 Nakayama M, Bando M, Araki K, Sekine T, Kurosaki F, Sawata T, Nakazawa S, Mato N, Yamasawa H, Sugiyama Y. Physical activity in patients with idiopathic pulmonary fibrosis: Physical activity in IPF. Respirology 2015;20:640-6. [DOI: 10.1111/resp.12500] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]
63 Vainshelboim B. Clinical Improvement and Effectiveness of Exercise-Based Pulmonary Rehabilitation in Patients With Idiopathic Pulmonary Fibrosis: A BRIEF ANALYTICAL REVIEW. J Cardiopulm Rehabil Prev 2021;41:52-7. [PMID: 33186196 DOI: 10.1097/HCR.0000000000000544] [Reference Citation Analysis]
64 Panagiotou M, Polychronopoulos V, Strange C. Respiratory and lower limb muscle function in interstitial lung disease. Chron Respir Dis 2016;13:162-72. [PMID: 26768011 DOI: 10.1177/1479972315626014] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]